The "sideways" VRAM flap for broad soft-tissue chest wall coverage von Suzman, Michael S

Volltext

Fascio-peritoneal patch repair of the IVC: a workhorse in search of work? von Suzman, Michael S, Smith, Andrew J, Brennan, Murray F

Volltext

Fascio-peritoneal patch repair of the IVC: a workhorse in search of work?1 von Suzman, Michael S, Smith, Andrew J, Brennan, Murray F

Volltext

Major burn injuries among restaurant workers in New York City: An underappreciated public health hazard von SUZMAN, Michael S, SOBOCINSKI, Krisha, HIMEL, Harvey, YURT, Roger W

Volltext

Accurate localization and surgical management of active lower gastrointestinal hemorrhage with technetium-labeled erythrocyte scintigraphy von SUZMAN, M. S, TALMOR, M, JENNIS, R, BINKERT, B, BARIE, P. S

Volltext

Letters to the Editor von Barie, Philip S., Talmor, Mia, Suzman, Michael S.

Volltext

Letter to the Editor von Barie, Philip S., Talmor, Mia, Suzman, Michael S.

Volltext

Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody von Maher, V Ellen, Fernandes, Laura L, Weinstock, Chana, Tang, Shenghui, Agarwal, Sundeep, Brave, Michael, Ning, Yang-Min, Singh, Harpreet, Suzman, Daniel, Xu, James, Goldberg, Kirsten B, Sridhara, Rajeshwari, Ibrahim, Amna, Theoret, Marc, Beaver, Julia A, Pazdur, Richard

Volltext

Clinical activity of enzalutamide versus docetaxel in men with castration-resistant prostate cancer progressing after abiraterone von Suzman, Daniel L., Luber, Brandon, Schweizer, Michael T., Nadal, Rosa, Antonarakis, Emmanuel S.

Volltext

FDA Approval Summary: Belzutifan for VHL Disease Tumors-Response von Fallah, Jaleh, Weinstock, Chana, Mehta, Gautam U, Brave, Michael H, Pierce, William F, Pazdur, Richard, Nair, Abhilasha, Suzman, Daniel L, Amiri-Kordestani, Laleh

Volltext

An FDA Review of Drug Development in Nonmetastatic Castration-resistant Prostate Cancer von Brave, Michael, Weinstock, Chana, Brewer, Jamie R, Chi, Dow-Chung, Suzman, Daniel L, Cheng, Joyce, Zhang, Lijun, Sridhara, Rajeshwari, Ibrahim, Amna, Kluetz, Paul G, Pazdur, Richard, Beaver, Julia A

Volltext

Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer von Boudadi, Karim, Suzman, Daniel L., Anagnostou, Valsamo, Fu, Wei, Luber, Brandon, Wang, Hao, Niknafs, Noushin, White, James R., Silberstein, John L., Sullivan, Rana, Dowling, Donna, Harb, Rana, Nirschl, Thomas R., Veeneman, Brendan A., Tomlins, Scott A., Wang, Yipeng, Jendrisak, Adam, Graf, Ryon P., Dittamore, Ryan, Carducci, Michael A., Eisenberger, Mario A., Haffner, Michael C., Meeker, Alan K., Eshleman, James R., Luo, Jun, Velculescu, Victor E., Drake, Charles G., Antonarakis, Emmanuel S.

Volltext

Advancing Assessment, Analysis, and Reporting of Safety and Tolerability in Cancer Trials von Kluetz, Paul G, King-Kallimanis, Bellinda L, Suzman, Daniel, Chang, Elaine, Brave, Michael M, Weinstock, Chana, Bhatnagar, Vishal, Beaver, Julia A, Chuk, Meredith K

Volltext

Bone-targeting agents in prostate cancer von Suzman, Daniel L., Boikos, Sosipatros A., Carducci, Michael A.

Volltext

Survival outcomes in older men with non-metastatic castration-resistant prostate cancer treated with androgen receptor inhibitors: a US Food and Drug Administration pooled analysis... von Fallah, Jaleh, Zhang, Lijun, Amatya, Anup, Gong, Yutao, King-Kallimanis, Bellinda, Bhatnagar, Vishal, Weinstock, Chana, Suzman, Daniel L, Agrawal, Sundeep, Chang, Elaine, Anscher, Mitchell S, Chi, Dow-Chung, Xu, James X, Brewer, Jamie R, Brave, Michael H, Hadadi, Mehrnoosh, Theoret, Marc R, Kluetz, Paul G, Goldberg, Kirsten B, Ibrahim, Amna, Tang, Shenghui, Pazdur, Richard, Beaver, Julia A, Amiri-Kordestani, Laleh, Singh, Harpreet

Volltext

Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development von Donaldson, Joshua M, Seddiq, Marjilla, Fusco, Michael J, Singla, Shyamli, Pamuk, Gulsum E, Lee-Alonso, Rosa J, Mixter, Bronwyn D, Goldberg, Kirsten B, Amiri-Kordestani, Laleh, de Claro, R Angelo, Drezner, Nicole, Gormley, Nicole J, Kanapuru, Bindu, Lemery, Steven J, Fashoyin-Aje, Lola A, Richardson, Nicholas C, Singh, Harpreet, Suzman, Daniel L, Theoret, Marc R, Kluetz, Paul G, Pazdur, Richard

Volltext

A U.S. Food and Drug Administration–pooled Analysis of Frontline Combination Treatment Survival Benefits by Risk Groups in Metastatic Renal Cell Carcinoma von Lee, Daniel, Gittleman, Haley, Weinstock, Chana, Suzman, Daniel, Bloomquist, Erik, Agrawal, Sundeep, Brave, Michael, Brewer, Jamie, Fallah, Jaleh, Singh, Harpreet, Tang, Shenghui, Ibrahim, Amna, Pazdur, Richard, Beaver, Julia A., Amiri-Kordestani, Laleh

Volltext

Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancer von Maughan, Benjamin L., Xhou, Xian C., Suzman, Daniel L., Nadal, Rosa, Bassi, Sunakshi, Schweizer, Michael T., Antonarakis, Emmanuel S.

Volltext

Temporal and regional patterns of prostate cancer positron emission tomography imaging among commercial insurance beneficiaries in the United States von Leapman, Michael, Long, Jessica B., Westvold, Sarah J., Rabil, Maximilian, Sprenkle, Preston, Kim, Isaac Yi, Saperstein, Lawrence, Fallah, Jaleh, Suzman, Daniel L., Lerro, Catherine, Xu, Jianjin, Kluetz, Paul Gustav, Karnes, R. Jeffrey, Kunst, Natalia, Wang, Shi-Yi, Ma, Xiaomei, Gross, Cary Philip

Volltext

FDA analysis of treatment-free survival in frontline advanced immuno-oncology–VEGF TKI renal cell carcinoma trials von Chang, Elaine, Zhou, Jiaxi, Song, Chi, Gittleman, Haley, Fernandes, Laura L., Weinstock, Chana, Atkins, Michael B., Agrawal, Sundeep, Sridhara, Rajeshwari, Gormley, Nicole, Amiri-Kordestani, Laleh, Tang, Shenghui, Kluetz, Paul, Suzman, Daniel L., Pazdur, Richard, Rini, Brian I., McDermott, David F., Regan, Meredith M.

Volltext